Poland· PL-100441936
Zynrelef
A anesthetics, local product containing bupivacainum + meloxicamum, registered in Poland by Heron Therapeutics, B.V.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Bupivacainum + meloxicamum is registered in 3 of 19 countries.
Countries holding a registration under ATC N01B (anesthetics, local), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Bupivacainum + meloxicamum · ATC N01B
3 / 19 countries
- Belgiumprice
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Bupivacainum + Meloxicamum
- Manufacturer
- Heron Therapeutics, B.V.
- Country
- Poland (PL)
- ATC code
- N01B
- ATC class
- ANESTHETICS, LOCAL
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bupivacainum + meloxicamum in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/233b5b30-e868-4aca-82d4-98d6220a6ac8 GET /v1/drugs/233b5b30-e868-4aca-82d4-98d6220a6ac8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór na ranę o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "(200 mg + 6 mg)/7 ml",
"packaging": "Rpz ¦ EU/1/20/1478/002 ¦ 137838\n1 fiol. 10,5 ml + 1 nakłuwacz do fiol. + 1 strzyk. 12 ml + 1 aplikator",
"substance": "Bupivacainum 200 mg + Meloxicamum 6 mg",
"common_name": "Bupivacainum + Meloxicamum",
"pl_product_id": "100441936",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": "2023-10-05"
}See everything about bupivacainum + meloxicamum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.